Meeting
2023 ASCO Genitourinary Cancers Symposium
Evaluating p53 nuclear expression and prostate cancer progression in a predominantly African American cohort.
Authors
William Gesztes
George Washington University Hospital, Washington, DC
William Gesztes , Coen Lap , Maryam Dalivand , Colleen Hamilton , Antonio Martha , Morgan Byrne , Guoqing Diao , Maneesh Rajiv Jain , Victor Nava
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 217)
DOI
10.1200/JCO.2023.41.6_suppl.217
Abstract #
217
Poster Bd #
H5
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Percent genome alteration and outcomes after radical prostatectomy in African American men.
First Author: Farzana A Faisal
Poster
2018 ASCO Annual Meeting
Effect of rilimogene galvacirepvec/rilimogene glafolivec on intra/peritumoral immune infiltrate in patients with localized prostate cancer undergoing radical prostatectomy.
First Author: James L. Gulley
Poster
2018 ASCO Annual Meeting
A pharmacodynamic biomarker study of vistusertib (AZD2014), an mTORC1/2 inhibitor, given prior to radical prostatectomy (CANCAP02).
First Author: Simon Pacey
Poster
2018 Genitourinary Cancers Symposium
Evaluating the impact of African American ancestry among men with localized prostate cancer treated with radical prostatectomy.
First Author: Daniel Canter